These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
721 related articles for article (PubMed ID: 10530344)
1. [Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis]. Doré MX; Dieumegard B; Grandjouan S; Avril MF; Martinet C; Ducreux M; Lasser P; Bressac-de Paillerets B Ann Dermatol Venereol; 1999; 126(8-9):582-6. PubMed ID: 10530344 [TBL] [Abstract][Full Text] [Related]
2. [Mutation in the MSH2 gene in Muir-Torre syndrome]. Godard V; Coulet F; Bernaudin JF; Housset M; Soubrier F Ann Dermatol Venereol; 1999; 126(8-9):600-3. PubMed ID: 10530347 [TBL] [Abstract][Full Text] [Related]
3. The Muir-Torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation. Suspiro A; Fidalgo P; Cravo M; Albuquerque C; Ramalho E; Leitão CN; Costa Mira F Am J Gastroenterol; 1998 Sep; 93(9):1572-4. PubMed ID: 9732950 [TBL] [Abstract][Full Text] [Related]
4. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714 [TBL] [Abstract][Full Text] [Related]
5. The frequency of Muir-Torre syndrome among Lynch syndrome families. South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343 [TBL] [Abstract][Full Text] [Related]
6. [Muir-Torre syndrome]. Lòngy M Ann Dermatol Venereol; 1999; 126(8-9):580-1. PubMed ID: 10530343 [No Abstract] [Full Text] [Related]
7. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy. Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463 [TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer and the Muir-Torre syndrome in a Gypsy family: a review. Lynch HT; Leibowitz R; Smyrk T; Fusaro RM; Lynch JF; Smith A; Franklin B; Stella A; Liu B Am J Gastroenterol; 1999 Mar; 94(3):575-80. PubMed ID: 10086635 [TBL] [Abstract][Full Text] [Related]
9. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families. Ponti G; Ponz de Leon M; Losi L; Di Gregorio C; Benatti P; Pedroni M; Scarselli A; Riegler G; Lembo L; Pellacani G; Seidenari S; Rossi G; Roncucci L Br J Dermatol; 2005 Jun; 152(6):1335-8. PubMed ID: 15949004 [TBL] [Abstract][Full Text] [Related]
10. Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypes. Huang RL; Chao CF; Ding DC; Yu CP; Chang CC; Lai HC; Yu MH; Liu HS; Chu TY Cancer Genet Cytogenet; 2004 Sep; 153(2):108-14. PubMed ID: 15350299 [TBL] [Abstract][Full Text] [Related]
11. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC). Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318 [TBL] [Abstract][Full Text] [Related]
13. Novel germline hMSH2 genomic deletion and somatic hMSH2 mutations in a hereditary nonpolyposis colorectal cancer family. Miyaki M; Iijima T; Yamaguchi T; Shirahama S; Ito T; Yasuno M; Mori T Mutat Res; 2004 Apr; 548(1-2):19-25. PubMed ID: 15063132 [TBL] [Abstract][Full Text] [Related]
14. [Muir-Torre syndrome]. Jonas J; Kruse R; Bähr R Chirurg; 2002 Apr; 73(4):366-9. PubMed ID: 12063922 [TBL] [Abstract][Full Text] [Related]
15. [Recognising hereditary non-polyposis colorectal cancer without a clear family history]. de Bruin JH; Nagengast FM; Ligtenberg MJ; van Krieken JH; Niermeijer MF; Hoogerbrugge N Ned Tijdschr Geneeskd; 2004 Oct; 148(42):2053-7. PubMed ID: 15532325 [TBL] [Abstract][Full Text] [Related]
16. A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome. Perera S; Ramyar L; Mitri A; Pollett A; Gallinger S; Speevak MD; Aronson M; Bapat B J Hum Genet; 2010 Jan; 55(1):37-41. PubMed ID: 19911012 [TBL] [Abstract][Full Text] [Related]
17. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge. Ponti G; Manfredini M; Tomasi A; Pellacani G Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115 [TBL] [Abstract][Full Text] [Related]
18. The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC. Ollila S; Fitzpatrick R; Sarantaus L; Kariola R; Ambus I; Velsher L; Hsieh E; Andersen MK; Raevaara TE; Gerdes AM; Mangold E; Peltomäki P; Lynch HT; Nyström M Int J Oncol; 2006 Jan; 28(1):149-53. PubMed ID: 16327991 [TBL] [Abstract][Full Text] [Related]
19. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors]. Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166 [TBL] [Abstract][Full Text] [Related]